Article
CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in murine model…
bioRxiv · 2023 · Aleksandr S. Chernov
Key facts
| Title | CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in murine model of the SARS-CoV-2-related acute respiratory distress syndrome |
|---|---|
| First author | Aleksandr S. Chernov |
| Journal | bioRxiv |
| Published | Nov 15, 2023 |
| DOI | 10.1101/2023.11.14.567145 |
| Devices mentioned | K800552, K852441, K853723, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185 and 23 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, EPT, GCJ and 11 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1